✦ LIBER ✦

Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient

✍ Scribed by Angela Shannon; Naim Alkhouri; Shadi Mayacy; Barbara Kaplan; Lori Mahajan

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 39 KB
Volume: 16
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metastatic Crohn's disease of the penis

Metastatic Crohn's disease of the penis in a pediatric patient

✍ John F. Pohl; Jessica M. Comstock; Siam Oottamasathien 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

Pyostomatitis vegetans as an oral manife

Pyostomatitis vegetans as an oral manifestation of Crohn's disease in a pediatric patient

✍ Fouseena Pazheri; Naim Alkhouri; Kadakkal Radhakrishnan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 1 views

Adalimumab for the treatment of fistulas

Adalimumab for the treatment of fistulas in patients with Crohn's disease

✍ Steven N. Fine 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

First detection of Helicobacter canis in

First detection of Helicobacter canis in chronic duodenal ulcerations from a patient with Crohn's disease

✍ Jacques Tankovic; Mounira Smati; Dominique Lamarque; Jean-Charles Delchier 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

Is the prolonged use of low-dose steroid

Is the prolonged use of low-dose steroids safe for Crohn's disease?

✍ Peter A. Banks; Daniel H. Present 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Bladder malignancy in a patient receivin

Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis

✍ Alan F. Ansher; John W. Melton III; Anthony J. Sliwinski 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Cyclophosphamide treatment of malignant disease has been strongly associated with an increased incidence of bladder cancer. Recently there have been 3 papers reporting 4 cases of bladder cancer in patients treated with cyclophosphamide for benign disease (1-3). However, there is no increased inciden